North American researchers eye ALS vaccine

Oct 05, 2007

Researchers from U.S. and Canadian universities said they are working on a vaccine for treating the degenerative condition known as Lou Gehrig's disease.

The researchers are developing a vaccine that would target a toxic protein in people with the genetic mutation -- found in a small percentage of cases of the neuro-muscular disease amyotrophic lateral sclerosis, the Montreal Gazette reported Friday.

"The particular protein that has been the subject of much discussion is one that is made in every cell of the body in very high quantities," Harvard University neuro-scientist Robert Brown said at the Montreal Neurological Institute, which is conducting a symposium this week on ALS.

In people with the genetic mutation, the protein becomes toxic, changing in a way that causes it to become unstable, "probably impairing many, many aspects of the motor neurons that will die," he said.

Brown and researchers from Universite Laval in Quebec City are conducting more research on the Canadians' work that showed such a vaccine targeting the toxic protein was effective in lab mice genetically bred with ALS.

Copyright 2007 by United Press International

Explore further: Large but unexplained variations in paracetamol-induced liver failure among European countries

Related Stories

New antibody insecticide targets malaria mosquito

May 20, 2015

Malaria is a cruel and disabling disease that targets victims of all ages. Even now, it is estimated to kill one child every minute. Recent progress in halting the spread of the disease has hinged on the ...

New 3-D method improves the study of proteins

Apr 27, 2015

Researchers have developed a new computational method called AGGRESCAN3D which will allow studying the 3D structure of folded globular proteins and substantially improve the prediction of any propensity for ...

New light on bacterial microcompartments

May 12, 2015

Bacteria contain "microcompartments," which are poorly understood organelles that play critical roles in metabolism. Understanding how they work may ultimately enable engineering them for useful applications. In salmonella, ...

Protein aggregates save cells during aging

May 08, 2015

As an organism ages, a gradual loss of cellular protein quality control occurs. This results in the increased production of toxic protein clumps, so-called aggregates. Using a comprehensive approach, researchers ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

May 22, 2015

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.